Fundraising FoxStemline Therapeutics
New York, US · 1 known investors
Find your way into Stemline Therapeutics
Sign up to find every way you can get introduced to Stemline Therapeutics
- Your email: who you already know at Stemline Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Stemline Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Stemline is an oncology-focused pharmaceutical company developing and commercializing cancer therapies, including ELZONRIS (tagraxofusp-erzs) for blastic plasmacytoid dendritic cell neoplasm and ORSERDU (elacestrant) for ER-positive, HER2-negative, ESR-1 mutated advanced or metastatic breast cancer. It is part of the Menarini Group, an international pharmaceutical and diagnostics company.
Founders & leadership
IB
Ivan Bergstein, M.D.Founder
Board
RB
Ronald BentsurBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$740K disclosed across 1 round · 2012
▶$740KraisedJan 2012 · 16 investors · PharmaceuticalsRule 506(b)
▶$740KraisedJan 2012 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ronald BentsurDirector
- Ivan Bergstein, M.D.Executive Officer, Director
- Amount sold
- $740K
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Stemline Therapeutics do?
- Stemline is an oncology-focused pharmaceutical company developing and commercializing cancer therapies, including ELZONRIS (tagraxofusp-erzs) for blastic plasmacytoid dendritic cell neoplasm and ORSERDU (elacestrant) for ER-positive, HER2-negative, ESR-1 mutated advanced or metastatic breast cancer. It is part of the Menarini Group, an international pharmaceutical and diagnostics company.
- Who founded Stemline Therapeutics?
- Stemline Therapeutics was founded by Ivan Bergstein, M.D..
- Who are Stemline Therapeutics's investors?
- Stemline Therapeutics's investors include Avoro Capital Advisors.
- How much funding has Stemline Therapeutics raised?
- Stemline Therapeutics has disclosed $740K raised across 1 round.
- Where is Stemline Therapeutics headquartered?
- Stemline Therapeutics is headquartered in New York, US.